GlaxoSmithKline Pharmaceuticals vs Peers
- Market cap
- ₹44,821 crore
- P/E
- 42.0
- P/B
- 19.77
- ROE
- 49.1%
- Dividend yield
- 1.20%
GlaxoSmithKline Pharmaceuticals ranks 17th by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 42.0 compares with a peer median of 33.6.
GlaxoSmithKline Pharmaceuticals vs Pharmaceuticals peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,773.60 | -1.69% | 4,25,546 | 35.2 | 5.09 | 14.7% | +12.5% |
| Divi's Laboratories | 9,586.00 | +0.38% | 2,54,478 | 87.0 | 15.18 | 16.2% | +12.5% |
| Torrent Pharmaceuticals | 4,693.90 | -1.64% | 1,58,863 | 72.8 | 18.94 | 27.1% | +12.5% |
| Zydus Lifesciences | 1,151.30 | -0.71% | 1,15,848 | 25.7 | 4.27 | 19.7% | +12.5% |
| Laurus Labs | 2,052.90 | +0.14% | 1,10,827 | 101.4 | 20.91 | 18.2% | +12.5% |
| Cipla | 1,333.00 | -0.54% | 1,07,677 | 32.0 | 3.13 | 11.8% | +12.5% |
| Mankind Pharma | 2,496.00 | -0.16% | 1,03,042 | 50.4 | 6.32 | 12.5% | +12.5% |
| Dr. Reddy's Laboratories | 1,194.90 | -1.08% | 99,533 | 30.1 | 2.60 | 12.1% | +12.5% |
| Aurobindo Pharma | 1,677.90 | -0.88% | 97,453 | 26.3 | 2.57 | 9.9% | +12.5% |
| Lupin | 2,006.70 | -1.11% | 91,742 | 16.6 | 4.09 | 26.9% | +12.5% |
| GlaxoSmithKline Pharmaceuticals | 2,645.80 | -3.96% | 44,821 | 42.0 | 19.77 | 49.1% | +22.0% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
GlaxoSmithKline Pharmaceuticals peer comparison — frequently asked questions
Who are GlaxoSmithKline Pharmaceuticals' competitors?
GlaxoSmithKline Pharmaceuticals' listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs and Cipla, ranked here by market capitalisation.
How does GlaxoSmithKline Pharmaceuticals' P/E compare with its peers?
GlaxoSmithKline Pharmaceuticals trades at a P/E of 42.0, against a median of 33.6 across the 10 Pharmaceuticals peers shown.
Which is the largest company among GlaxoSmithKline Pharmaceuticals' peers?
By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹44,821 crore for GlaxoSmithKline Pharmaceuticals.
Same Data For Peers
Trade GlaxoSmithKline Pharmaceuticals With ATS
Track GLAXO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.